We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
10 hedge funds and large institutions have $322K invested in Atossa Therapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.04% less ownership
Funds ownership: 0.22% → 0.18% (-0.04%)
29% less funds holding
Funds holding: 14 → 10 (-4)
32% less capital invested
Capital invested by funds: $471K → $322K (-$150K)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
10
Holders Change
-4
Holders Change %
-28.57%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$4.07K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$1.3K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$79 |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$41K |
| 2 |
AIP
Ahrens Investment Partners
Lafayette,
Louisiana
|
-$16K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$9K |